| | | | | | | | | | |
|
| |
|
| Dockets Entered
On February 9, 2005
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| 2004D-0509
|
| Certification of Fish and Fishery Products for Export to the European Union and the European Free Trade Association
|
|
|
|
|
| 2004D-0510
|
| Live & Perishable Fish & Fishery Products for Export to the European Union and the European Free Trade Association
|
|
|
|
|
| 2004N-0416
|
| Beverages: Bottled Water
|
|
|
|
|
| 2004N-0454
|
| Dietary Supplements; Premarket Notification for New Dietary Ingredient Notifications; Public Meeting
|
|
|
|
|
| 2004N-0479
|
| Draft Risk Assessment of Streptogramin Resistance in Enterococcus faecium Attributable to the Use of Streptogramins in Animals; Availability
|
|
|
|
|
| 2004N-0516
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; 2005 Food Safety Survey
|
|
|
|
|
| 2004P-0472
|
| refuse final approval to ANDA 76-258 for a generic fentanyl transdermal lsystem under it current proposed labeling
|
|
|
|
|
| 2004P-0506
|
| fentanyl transdermal products reduce the potential for abuse of certain types of these products
|
|
|
|
|
| 2004Q-0072
|
| QHC Eggs w/Enhanced omega-3 fatty acid content and reduced risk of heart disease and sudden fatal heart attack
|
|
|
|
|
| 2004Q-0151
|
| Qualified Health Claim (QHC): soy protein and cancer
|
|
|
|
|
| 2005N-0012
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Allergen Labeling of Food Products Consumer Preference Survey and Experimental Study on Allergen Labeling of Food Produc
|
|
|
|
|
|
|
|
|
| 2005N-0036
|
| Use of Color on Pharmaceutical Product Labels, Labeling and Packaging; Public Hearing
|
|
| |
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| LET
15477
|
| Enzymatic Therapy
|
| Vol #:
|
| 136
|
|
|
|
|
| LET
15478
|
| Enzymatic Therapy
|
| Vol #:
|
| 136
|
|
|
|
|
| LET
15479
|
| NBTY Inc.
|
| Vol #:
|
| 136
|
|
|
|
|
| LET
15480
|
| NBTY Inc.
|
| Vol #:
|
| 136
|
|
|
|
|
| LET
15481
|
| NBTY Inc.
|
| Vol #:
|
| 136
|
|
|
|
|
| LET
15482
|
| NBTY Inc.
|
| Vol #:
|
| 136
|
|
|
|
|
| LET
15483
|
| NBTY Inc.
|
| Vol #:
|
| 136
|
|
|
|
|
| LET
15484
|
| NBTY Inc.
|
| Vol #:
|
| 136
|
|
|
|
|
| LET
15485
|
| NBTY Inc.
|
| Vol #:
|
| 136
|
|
|
|
|
| LET
15486
|
| Renaissance Herbs
|
| Vol #:
|
| 136
|
|
|
|
|
| LET
15487
|
| NBTY Inc.
|
| Vol #:
|
| 136
|
|
|
|
|
| LET
15488
|
| NBTY Inc.
|
| Vol #:
|
| 136
|
|
|
|
|
| LET
15489
|
| NBTY Inc.
|
| Vol #:
|
| 136
|
|
|
|
|
| LET
15490
|
| NBTY Inc.
|
| Vol #:
|
| 136
|
|
|
|
|
| LET
15491
|
| Leiner Health Products
|
| Vol #:
|
| 136
|
|
|
|
|
| LET
15492
|
| Leiner Health Products
|
| Vol #:
|
| 136
|
|
|
|
|
| LET
15493
|
| Leiner Health Products
|
| Vol #:
|
| 136
|
|
|
|
|
| LET
15494
|
| Leiner Health Products
|
| Vol #:
|
| 136
|
|
|
|
|
| LET
15495
|
| Leiner Health Products
|
| Vol #:
|
| 136
|
|
|
|
|
| LET
15496
|
| Leiner Health Products
|
| Vol #:
|
| 136
|
|
|
|
|
| LET
15497
|
| Leiner Health Products
|
| Vol #:
|
| 136
|
|
| | | | | | | | |
|
|
|
| 2004N-0479
|
| Draft Risk Assessment of Streptogramin Resistance in Enterococcus faecium Attributable to the Use of Streptogramins in Animals; Availability
|
|
|
|
|
| EMC
1
|
| Canberra Hospital
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0516
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; 2005 Food Safety Survey
|
|
|
|
|
| EC
18
|
| Food Allergy & Anaphylaxis Network
|
| Vol #:
|
| 1
|
|
|
|
|
| EC
19
|
| Partnership for Food Safety Education
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004P-0472
|
| refuse final approval to ANDA 76-258 for a generic fentanyl transdermal lsystem under it current proposed labeling
|
|
|
|
|
| EMC
3
|
| Wiley Rein & Fielding, LLP
|
| Vol #:
|
| 2
|
|
|
|
|
| 2004P-0506
|
| fentanyl transdermal products reduce the potential for abuse of certain types of these products
|
|
|
|
|
| EMC
2
|
| Wiley Rein & fielding, LLP
|
| Vol #:
|
| 2
|
|
|
|
|
| 2004Q-0072
|
| QHC Eggs w/Enhanced omega-3 fatty acid content and reduced risk of heart disease and sudden fatal heart attack
|
|
|
|
|
| LET
4
|
| AAC Consulting Group
|
| Vol #:
|
| 4
|
|
|
|
|
| 2004Q-0151
|
| Qualified Health Claim (QHC): soy protein and cancer
|
|
|
|
|
| LET
4
|
| The Solae Company
|
| Vol #:
|
| 5
|
|
|
|
|
| 2005N-0012
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Allergen Labeling of Food Products Consumer Preference Survey and Experimental Study on Allergen Labeling of Food Produc
|
|
|
|
|
|
|
|
|
| EMC 1
|
| B. Sachau
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005N-0036
|
| Use of Color on Pharmaceutical Product Labels, Labeling and Packaging; Public Hearing
|
|
|
|
|
| HER
1
|
| American Medical Association (AMA)
|
| Vol #:
|
| 1
|
|
